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Abstract
Hepatitis C virus (HCV) enters hepatocytes following a complex set of receptor interactions, culminating in internalization
via clathrin-mediated endocytosis. However, aside from receptors, little is known about the cellular molecular requirements
for infectious HCV entry. Therefore, we analyzed a siRNA library that targets 140 cellular membrane trafficking genes to
identify host genes required for infectious HCV production and HCV pseudoparticle entry. This approach identified 16 host
cofactors of HCV entry that function primarily in clathrin-mediated endocytosis, including components of the clathrin
endocytosis machinery, actin polymerization, receptor internalization and sorting, and endosomal acidification. We next
developed single particle tracking analysis of highly infectious fluorescent HCV particles to examine the co-trafficking of
HCV virions with cellular cofactors of endocytosis. We observe multiple, sequential interactions of HCV virions with the actin
cytoskeleton, including retraction along filopodia, actin nucleation during internalization, and migration of internalized
particles along actin stress fibers. HCV co-localizes with clathrin and the ubiquitin ligase c-Cbl prior to internalization.
Entering HCV particles are associated with the receptor molecules CD81 and the tight junction protein, claudin-1; however,
HCV-claudin-1 interactions were not restricted to Huh-7.5 cell-cell junctions. Surprisingly, HCV internalization generally
occurred outside of Huh-7.5 cell-cell junctions, which may reflect the poorly polarized nature of current HCV cell culture
models. Following internalization, HCV particles transport with GFP-Rab5a positive endosomes, which is consistent with
trafficking to the early endosome. This study presents technical advances for imaging HCV entry, in addition to identifying
new host cofactors of HCV infection, some of which may be antiviral targets.
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Introduction
Hepatitis C virus (HCV) contains a small positive stranded
RNA (,9600 bp) genome encased by a capsid and surrounded by
a lipid bilayer envelope containing the glycoproteins, E1 and E2
[1]. Delivery of the RNA genome to a protected site for replication
depends on successful entry and trafficking in a hepatocyte.
Studies using recombinant glycoproteins, HCV pseudoparticles
(HCVpp), which are lentiviral vectors that incorporate the HCV
glycoproteins E1 and E2 on the viral envelope, and more recently
the infectious HCV cell culture system (HCVcc), have defined
important HCV-receptor interactions [2–14]. Circulating HCV in
the blood is associated with serum lipoproteins and requires an
orchestrated engagement of receptors on target cells [15–19].
Initial attachment may be mediated by cell surface glycosamino-
glycans and the LDL-receptor [8,20,21] of hepatocytes. Subse-
quent internalization of HCV requires a complex set of receptor
molecules including, the tetraspannin molecule CD81, scavenger
receptor B-1 (SR-BI), and the tight junction proteins claudin(s)
(CLDN)-1, -6, -9, and occludin (OCDN) to bind and enter into
hepatocytes [2–14,22–26]. HCV internalization has never been
visualized, but is postulated to occur at the tight junction where the
entry receptors claudin-1 and occludin localize. Recombinant,
soluble E2 re-localizes the CD81 receptor to the tight junction.
Engagement of CD81 also activates the Rho GTPase, CDC42,
which may result in actin cytoskeletal rearrangements that would
allow for trafficking of HCV to the tight junction [27].
Small interfering RNAs (siRNAs) targeting the clathrin machin-
ery inhibit HCV entry, suggesting that HCV uses clathrin-mediated
endocytosis, however, HCV has not yet been visualized within a
clathrin coated vesicle [28,29]. Once internalized, it is thought that
HCV traffics to the early endosome prior to viral RNA release [29].
Inhibitors of endosomal acidification block HCV entry, which
indicatespH-dependentfusionbetweentheenvelopeandendosome
is needed to release the genomic content [2,28-31]. Dominant–
negative mutants of early, but not late, endosomal proteins block
HCVpp entry, suggesting that HCV fuses from early endosomes
[29]. These data lead to a model of HCV entry wherein the HCV
virion initially engages the CD81 and SR-B1 co-receptors, then
migrates to the tight junction where it interacts withits co-receptors,
claudin-1, -6, or -9, and occludin. Clathrin-mediated endocytosis
occurs at the tight junction and early endosomal acidification results
in fusion, uncoating, and release of the HCV RNA genome into the
cytosol [32]. Much of this model remains untested. In particular, we
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HCV endocytosis and characterizing the trafficking of HCV virions
in real time.
In this study, we have undertaken a combinatorial approach to
understanding HCV entry into hepatocytes. We, and others, have
previously relied on RNA interference (RNAi) analysis to identify
cellular cofactors of HCV replication [33–38]. These studies have
generally used HCV sub-genomic replicons, which do not produce
infectious virus and as such, cannot be used to study HCV entry or
egress [7]. The only siRNA study using infectious HCV focused on
cellularproteinsthat interact withHCVandidentified fewtargets of
interest for HCV endocytosis [35]. It is likely that the major virus-
cell interactions that were missed in these analyses are the roles of
host membrane trafficking pathways in HCV infection, since this
encompasses various endocytic and secretory pathways. Therefore,
we began this study by evaluating a siRNA library targeting 140
genes involved in membrane trafficking pathways to identify human
genes required for infectious HCV production and HCVpp entry.
From the siRNA study, we identified several cellular genes involved
in the clathrin-mediated endocytosis pathway. Next, we established
single particle tracking approaches to image fluorescent HCV
particles in live cells, based on a similar approach used with Dengue
virus [39]. We demonstrate co-localization and co-trafficking of
HCVvirionswith numerouscellularmarkersidentifiedinthe RNAi
analysis. Here, we provide evidence that HCV traffics initially with
filopodia, then its co-receptors, CD81 and claudin-1, and is
internalized into Huh-7.5 cells at regions not restricted to the tight
junction. Internalization is associated with the clathrin light chain,
actin, and the E3 ubiquitin ligase c-Cbl. Intracellular HCV is
associated with early endosomespositiveforRab5a GTPaseand are
likely to fuse out of endosomes, dependent on a vacuolar ATPase,
encoded by the ATP6V0A1 gene.
Results
Host genes involved in HCV endocytosis
We began this study by interrogating a previously described
unique siRNA library that targets known membrane trafficking
pathways [33]. The base of this library is a commercially available
set of 122 siRNAs targeting membrane trafficking genes from
Dharmacon, Inc. that was supplemented with genes involved in
fatty acid synthesis, COPI vesicles, ADP ribosylation factors,
autophagy, and secretion. Genes targeted in this library also
include those involved in clathrin-mediated endocytosis, caveolae,
macropinocytosis, cytoskeletal organization, and phosphatidyl
inositol signaling. Analysis of this library provides an unbiased
assessment of the relative contributions of these pathways to HCV
endocytosis.
We first identified siRNAs that inhibited infectious HCV
production and then re-tested these siRNAs using HCVpp that
contain a luciferase reporter gene. The rationale for this approach
was to do a primary evaluation of host cofactors using the most
authentic system (HCVcc) and then distinguish host genes
involved in HCV endocytosis from those acting at later stages of
the viral life cycle by using HCVpp. Huh-7.5 cells were transfected
with a pool of four siRNAs that target a specific host gene,
incubated 72 hours to establish silencing, then inoculated for 16 h
with HCV. Infection was maintained for a total of two days, after
which supernatants were collected and infectious HCV was
quantified in duplicate by limiting dilution titration. Infectious
HCV production following siRNA treatment was then normalized
to the amount of HCV produced following treatment with four
independent irrelevant siRNAs (Table 1). siRNAs targeting 44
genes altered infectious HCV production greater than one
standard deviation from the irrelevant siRNAs (greater than
2.8-fold) and these were prioritized for follow up in the HCVpp
entry assay. The siRNA pools were individually introduced into
Huh-7.5 cells and subsequently infected with HCVpp. Luciferase
values were measured 48 hours after HCVpp infection and
Author Summary
Hepatitis C virus (HCV) chronically infects 130 million
people and is a major cause of cirrhosis and liver cancer.
The current antiviral therapy of pegylated interferon-2 alfa
+ ribavirin is successful in only half of treated patients. This
has led to an intensive effort to design improved
therapeutic strategies. The identification of cellular cofac-
tors of HCV infection greatly expands the pool of potential
targets for drug design. In this paper, we combine RNA
interference analysis of HCV endocytosis with the devel-
opment of live cell imaging of highly infectious HCV
particles. We identify 16 host cofactors of HCV entry, most
of which function in sequential stages of clathrin-mediated
endocytosis. We observe the trafficking of fluorescent HCV
particles with these cellular cofactors and their related
pathways, including the actin cytoskeleton, known recep-
tors CD81 and the tight junction protein claudin-1,
clathrin, an E3 ubiquitin ligase, and early endosomes.
Surprisingly, given the role of tight junction proteins as
HCV entry factors, virion entry generally occurred outside
of cell-cell junctions. This paper identifies novel host
targets for therapeutic development, describes techniques
to image HCV entry, and provides insights into HCV-cell
interactions in the entry process.
Table 1. Cellular cofactors of HCV endocytosis.
siRNA Percent Inhibition
{ Gene Function
HCVpp HCVcc Host Gene RNA
CLTCL1 73+6.4 69+12 69+1.3 clathrin coat
CLTB 63+4.1 84+12 91+1.2 clathrin coat
HIP1R 26+3.6 66+17 74+1.9 clathrin coat
HIP1 48+6.2 81+15 52+4.4 clathrin coat
EPN1 35+4.7 71+12 77+0.2 clathrin/actin
EPN3 28+4.3 84+8.6 69+2.8 clathrin/actin
CFL1 85+4.4 89+8.1 86+1.7 actin polymerization
CDC42 56+6.8 78+16* 95+0.3 actin polymerization
ROCK2 41+3.7 77+19* 77+0.2* actin polymerization
AP2M1 39+5.2 279+15
{ 88+2.0 AP2 adaptor
SYT1 64+7.9 72+13 65+0.4 AP2/clathin recruitment
CBL 57+7.3 72+12 WB ubiquitin ligase
HGS 28+5.2 71+12 70+0.6 ubiquitylated receptor
sorting
ATP6V0A1 54+6.5 76+13 59+3.8 endosomal acidification
STAU 50+7.1 72+13 N/A ER/Golgi trafficking
RAB7L1 53+6.4 81+8.3* 85+5.4* Rab GTPase
{=Values represent % inhibition plus SEM of the geometric mean as compared
to irrelevant siRNA treatment.
{=A negative value reflects an increase in secretion of infectious virus.
*=Values previously published in reference [33].
WB=confirmed by western blot; N/A=not available.
doi:10.1371/journal.ppat.1000702.t001
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siRNAs that inhibited HCVpp luciferase expression by greater
than one standard deviation (1.35-fold) were classified with a
defect in HCV endocytosis. Specificity controls for the RNAi study
included measuring cell viability (Figure S1), demonstrating that
multiple siRNAs produce a consistent phenotype (Table S1), and
confirming that the target genes were indeed silenced by the
indicated siRNA using gene-specific real time RT-PCR assays
(Table S2). In total, 16 host genes were identified that satisfied all
criteria (Table 1).
Overall, the RNAi data implicate the clathrin-mediated
endocytosis pathway, including genes that encode clathrin coat
components (CLTB, CLTCL1, HIP1, and HIP1R); AP-2 adaptor
(AP2M1); AP-2-clathrin recruitment during endocytosis (SYT1)
[40]; proteins linking clathrin and the actin cytoskeleton (EPN1
and EPN3); and proteins controlling actin polymerization (CFL1,
CDC42 and ROCK2). c-CBL encodes an E3 ubiquitin ligase
linked to receptor endocytosis and receptor tyrosine kinase
signaling. Hgs is involved in the sorting of ubiquitylated receptors
and invagination of endosomal membranes during trafficking from
the early endosome to the late endosome or multivesicular body
[41]. The vacuolar ATPase, ATP6v0a1, is involved in endosomal
acidification and may function in the pH-dependent uncoating of
the HCV genome. The requirement of host proteins that function
in clathrin-dependent endocytic pathways and endosomal acidi-
fication for HCV endocytosis is supported by previous studies
demonstrating that inhibition of these processes by chlorproma-
zine (clathrin coated pit inhibitor), bafilomycin A1 (vesicular
protein ATPase inhibitor), ammonium chloride or chloroquine
(inhibit endosomal acidification) inhibit HCV entry [28,29,31].
siRNAs targeting CDC42, ROCK2, and Rab7L1 inhibit sub-
genomic HCV replication in addition to HCV entry [33],
suggesting multiple roles for these genes in the HCV life cycle.
Production of highly infectious fluorescent HCV particles
We next developed approaches to visualize the association of
HCV virions with the host endocytic machinery. To detect single
HCV particle entry events in Huh-7.5 cells, we labeled virions
with the membrane-permeable lipophilic dyes, DiD or DiI.
Previous reports show this approach was successful in labeling
Dengue virus and influenza virus for single particle imaging in live
cells without affecting viral infectivity [39,42-44]. Incorporation of
DiD did not have deleterious effects on HCV infectivity (Table 2).
The specific infectivity of HCV that is isolated from cell culture
supernatants is approximately 1000 (where 1 in 1000 HCV
particles lead to a productive infection) [7]. Poor specific infectivity
limits the ability to track fluorescent HCV particles with
confidence that they represent a productive infection. Therefore,
we purified a highly infectious fraction of DiD-labeled HCV (DiD-
HCV). We exploited the property that HCV isolated from cell
culture supernatants and patients possesses a range of densities
[45]. The different densities are attributed to the association of
low-density and very-low-density lipoprotein with virions [7,15].
The majority of HCV RNAs sediment at a density of ,1.15 g/ml,
while a highly infectious fraction of HCV is associated with a lower
density (,1.06 g/ml) [7,19,45]. DiD-HCV was separated by
sucrose gradient density ultracentrifugation, fractions were col-
lected, and the fraction density, infectious HCV and HCV RNA
copy numbers were quantified (Figure 1). Purified DiD-HCV had
a significantly improved specific infectivity of 10.568.5 (Table 2).
This improved specific infectivity greatly increases confidence that
we can visualize relevant HCV entry events; however, there
remains a caveat that ,90% of the purified, labeled particles do
not lead to productive infection.
The majority of DiD-labeled viral particles have an equivalent
size based on fluorescence emissions, suggesting we were imaging
single viral particles (Figure 2A). Additionally, the number of
fluorescent DiD particles per cell corresponded to our predicted
number of HCV virions, based on HCV RNA copy number
quantitation of the inoculum. To confirm the DiD signal is specific
to labeled HCV particles, we immuno-stained DiD-HCV particles
from our highly infectious fraction with an E2 antibody (CBH-5)
which recognizes E2 on extracellular released virions [46,47].
Co-localization between DiD and E2 was quantified (Figure 2A).
Overall, 95.761.3% of DiD particles immuno-stained for E2.
Next we tested if the DiD-HCV particles could be depleted in the
presence of the anti-E2 antibody, CBH-5. Anti-E2 immuno-
depletion resulted in an 86.6% reduction in DiD signal compared
to input inoculum, while the isotype control antibody (R04) did
not alter DiD signal (Figure 2B and 2C).
We next quantified DiD-core co-localization over a time course
of infection to determine the kinetics of virion uncoating. In this
assay, uncoating is defined as DiD-labeled envelope that no longer
co-localizes with the HCV capsid. Huh-7.5 cells were infected at
4uC for 1 hour to allow binding of the virus, shifted to 37uCt o
allow HCV entry, fixed and processed for immunofluorescence
detection of core protein (Figure 2D). 89.663.48% (n=77) of DiD
labeled particles were core positive at time zero, indicating efficient
labeling of the virus. We found that the majority of uncoating is
complete within two hours of the temperature shift, with 50% of
uncoating occurring 85 minutes after temperature shift (Figure 2E).
The kinetics of DiD-HCV uncoating are similar to what has been
Figure 1. Purification of highly infectious DiD-HCV particles.
Polyethylene glycol concentrated HCV was labeled with DiD (5 mM),
layered on a 20–80% sucrose gradient, and purified by ultracentrifu-
gation. Top of the gradient is fraction 1. Infectious HCV (solid line, left
y-axis) was quantified by titration, while HCV RNA copy numbers
(dashed line, right y-axis) were quantified by real time RT-PCR. Note the
different scales for each y-axis.
doi:10.1371/journal.ppat.1000702.g001
Table 2. Fluorescent HCV infectivity.
Virus Specific Infectivity (SI)
HCV 2009 (6450)
DiD-HCV 1018 (6346)*
Purified DiD-HCV 10.5 (68.5)**
*no significant difference between HCV and DiD-HCV (p=.52).
**average density=1.066.03 g/mL.
doi:10.1371/journal.ppat.1000702.t002
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enter through pH-dependent endocytosis, we performed the
uncoating assay in parallel in the presence of NH4Cl, which
neutralizes acidic endosomal compartments and has previously
shown to inhibit HCV entry [31]. DiD-core colocalization did not
significantly decrease at times post temperature shift in NH4Cl
treated cells, indicating that DiD-HCV uncoating requires
endosomal acidification (Figure 2E).
Finally, we tested whether DiD-HCV entry and uncoating
requires the receptor, CD81 [9]. We treated Huh-7.5 cells with
either irrelevant or CD81 siRNAs for two days and then performed
the uncoating assay (Figure 2F). We observed significant DiD-HCV
Figure 2. Characterization of DiD-HCV particles. A. DiD-HCV particles from the high specific infectivity fraction (density ,1.06 g/mL) were
spotted onto poly-lysine treated coverslips and immunostained with the HCV E2 monoclonal antibody, CBH5. B. DiD-HCV was immunodepleted using
anti-E2 (CBH5) or isotype control (RO4). 10 mL of unbound particles were spotted onto coverslips and fluorescence images were acquired. C. DiD
signal from (B) was quantified using the Image J plugin, measure particles. D. Huh-7.5 cells were infected with DiD-HCV for 1 hour on ice and fixed in
4% paraformaldehyde. The DiD-HCV was probed with HCV core monoclonal antibody. Shown are images of DiD-HCV envelope and core (capsid)
colocalization at T=0 (top) and T=60 mpi post temperature shift (bottom). Arrow denotes DiD-core colocalization at 60 mpi, whereas the square
denotes DiD no longer co-localizing with HCV core. E. Co-localization of DiD-envelope and core as determined by immunofluorescence was
performed over time in the presence or absence of the endosomal inhibitor NH4Cl (100 mM). Co-localization was quantified at the indicated time
points. Values are reported as percent of DiD particles positive for core staining. n=total DiD signal. Error bars represent standard error of
proportions for percent co-localization. Asterisks indicate means are significantly different from T=0 time point for untreated cells, p=0.0001. F. Huh-
7.5 cells were electroporated with irrelevant (siIRR) or CD81 (siCD81) siRNAs, maintained for two days and then the uncoating assay was performed as
in (E), p=0.0001.
doi:10.1371/journal.ppat.1000702.g002
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co-localization at T=0 to 31% DiD-core co-localization at T=120
minutes). In contrast, CD81 siRNAs inhibited DiD-HCV uncoat-
ing. We found only a modest reduction in DiD-HCV uncoating in
the CD81 silenced cells (from 81% DiD-core co-localization at
T=0 to 73% DiD-core co-localization at T=120 minutes). Thus,
DiD-HCV entry and uncoating requires CD81. Taken together,
these experiments demonstrate that DiD-HCV particles efficiently
co-localize with viral structural antigens and have the same cellular
requirements for entry, CD81 and endosomal acidification, as does
native HCV.
Localization of HCV with the actin cytoskeleton
Our siRNA studies indicated a role for actin and clathrin-actin
association for efficient HCV endocytosis. Several viruses have
been shown to rely on retrograde transport from actin-rich
filopodia or retraction fibers to the cell body before becoming
internalized [48-51]. The role of actin in HCV entry was
investigated by fluorescence microscopy in both fixed and live
cells. Huh-7.5 cells were infected with DiD-HCV on ice for
1 hour, then shifted to 37uC, fixed at various time points after the
temperature shift, and stained for F-actin (Figure 3A). At early
time points, fluorescent viral particles were found associated with
filopodia protruding from the cell surface. Viral particles were
found associated with the base of the filopodia during the first 30
minutes post temperature shift and decreased at later time points.
DiD-HCV particles also associated with cortical actin and actin
stress fibers at later time points (Figure 3B). We did not observe
any significant morphological changes to the cortical actin
cytoskeleton compared to uninfected cells during entry time
points as previously reported [27].
Live cell imaging of HCV and actin surface dynamics
We next examined the dynamic associations of HCV with actin
during endocytosis in live cells. We infected Huh-7.5 cells that
were transiently expressing GFP-actin [52] at multiplicities of
infection that result in approximately four bound DiD-HCV
particles per cell. Infections were maintained on ice for 1 hour to
allow for binding but not internalization, and then unbound
particles were washed off. DiD-HCV transport was visualized
every 5 seconds for several minutes following a shift to 37uC.
Individually moving DiD-HCV particles were tracked and the
trajectories of particle movements were determined (Figure 4).
Bound DiD-HCV particles exhibited heterogeneous movement
where many particles had limited mobility, while some displayed
highly active trajectories. Distinct particle trajectories included
processive linear movement, random movement, or restricted
movement in a minimal area (Figure 4A, B, or C, respectively).
85%63.6% (n=55) of motile particles were associated with actin
during transport. At early time points post temperature shift, DiD-
HCV particles localized with actin-rich filopodia. Figure 4A (Video
S1) depicts a DiD-HCV particle bound to a filopodia, followed by
transport of the particle towards the plasma membrane at an
average velocity of 0.08260.008 mm/sec, which is consistent with
retrograde actin flow. Overall, DiD-HCV particles that associate
with actin filaments move at an average velocity of 2.0761.5 mm/
min (Figure 4E). DiD-HCV particles that associated with the
plasma membrane, but not filopodia or actin stress fibers, either
moved randomly or were relatively static (Figure 4B, Video S2).
Thisresultwassurprising, sinceengagement ofCD81 withantibody
or soluble HCV E2 has been reported to initiate a directed
migration to cell-cell junctions that is associated with actin [27].
Therefore, we performed a quantitative mean square displacement
(MSD) analysis of HCV movements at the cell surface. DiD-HCV
particles moving in association with filopodia or stress fibers possess
a MSD curve associated with active transport (Figure 4F, sample A).
In contrast, DiD-HCV particles at the plasma membrane, which
are only transiently localized with actin, have a MSD curve
representative of diffusion (Figure 4F, sample B). It is possible that
DiD-HCV displays diffuse movement on the cell surface until a
clathrin-coated pit is found for internalization to occur, as has
recently been shown for the related Dengue virus [42].
Static, surface-bound HCV particles were either immobile (and
possibly non-infectious); or alternatively, they were associated with
actin rich clusters that occasionally nucleated from the DiD-HCV
particle. An example of actin nucleation associated with particle
internalization is shown in Figure 4C (Video S3), wherein an actin
filament nucleates adjacent to the DiD-HCV particle, then surrounds
the base of the particle, followed by the particle leaving the focal
plane, likely due to internalization. This is reminiscent of the
clustering of actin around a clathrin-coated pit during endocytic
internalization [53,54]. Additionally, DiD-HCV particles were found
to transport with nucleating actin clusters (Figure 4D, Video S4).
HCV is associated with actin following internalization
We next examined HCV-actin interactions following internal-
ization (Figure 5B–D). In the first 10 minutes of imaging,
Figure 3. HCV localizes to actin rich filopodia and stress fibers during entry. DiD-HCV was allowed to bind to Huh-7.5 cells on ice for 1 hour
followed by temperature shift to 37uC. Cells were fixed at 30 minutes post temperature shift (A) or 60 minutes post temperature shift (B) and stained
for actin using Alexa Fluor 488 phalloidin (A) or were expressing GFP-actin (B). Enlarged insets are shown on the right. Scale bars=10 mm. A. Inset
shows DiD-HCV association with filopodia (top) and cortical actin cytoskeleton. B. Inset shows DiD-HCV association with actin stress fibers along the
plasma membrane.
doi:10.1371/journal.ppat.1000702.g003
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internalization into the cytoplasm. Once inside the cell, the viral
particle migrates toward a pre-formed actin stress fiber and is then
transported along the stress fiber at an average velocity of 1.8 mm/
min. To confirm that this was indeed actin-based motility, we
tested whether treatment with cytochalasin D would interfere with
the entry process. We first showed that pretreatment of Huh-7.5
cells with cytochalasin D produces a dose-dependent inhibition of
HCVpp entry (Figure 5A). Then, we treated the infected cells
shown in Figure 5B with 2 mM cytochalasin D at 20:15 (minutes:
seconds) of imaging (Figure 5C, Video S5). Treatment stalled DiD-
HCV migration along the stress fiber for the remainder of
imaging, as shown in Figure 5C. To determine whether particles
associated with actin stress fibers were internalized, we treated
DiD-HCV infected cells with 0.2% trypan blue to quench the DiD
fluorescence of extra-cellular DiD-HCV particles. We observe that
stress fiber-associated viral particles were resistant to fluorescence
quenching, indicating they are internalized. 75% (SEp66.5,
n=44) of fluorescent DiD-HCV particles after quenching were
associated with phalloidin stained actin stress fibers. Also we did
not detect DiD-HCV particles associated with filopodia after
quenching with trypan blue, indicating that these DiD-HCV
particles are extra-cellular (data not shown).
HCV is associated with the clathrin-mediated endocytosis
machinery
Our RNAi data implicate clathrin-mediated endocytosis in
HCV entry, as has been previously reported using siRNA and
inhibitor studies. [28,29,31]. We tested the association of HCV
with clathrin by infecting Huh-7.5 cells with DiD-labeled virus at
4uC for 1 hour, then shifted to 37uC and fixed at various time-
points after the temperature shift. Cells were immuno-probed for
clathrin light chain, a component of clathrin triskelions (Figure 6A).
Z-stack analysis shows clathrin light chain associated beneath a
DiD-HCV particle (Figure 6C). 28.3% (SEp65.8%, n=60) of
cell-associated DiD-labeled HCV particles co-localized with
clathrin light chain at zero minutes post infection whereas
maximal association 58.8% (SEp66.9%, n=58) of cell associated
particles occurred around 15 minutes post infection (Figure 6H).
In a recent report from Schwarz et al, HCV bound to cells is
internalized within 23 minutes and is consistent with the time
points when we observe maximal association with clathrin light
chain (Figure 6H) [55].
The E3 ubiquitin ligase, c-Cbl, was identified as an entry
cofactor in our siRNA screen and has been shown to mediate
receptor internalization by ubiquitylating the cytosolic domains of
Figure 4. HCV entry dynamics in association with the actin cytoskeleton. Huh-7.5 cells transiently expressing GFP-actin (green) were
infected with DiD-HCV on ice for 1 hour then shifted to 37uC upon imaging. Shown are representative montages of alternating time-lapse exposures
of Cy5 (DiD-HCV) and GFP (actin) during entry. Scale bar=10 mm. A. DiD-HCV uses filopodia-associated transport to reach the cell body. Right:
Trajectory tracing depicting the path followed by the DiD-HCV particle during imaging. Arrow points to the origin of transport for the trajectory. Scale
bar=10 mm. B. DiD-HCV particle displaying random movement not associated with actin. Right: Trajectory of particle shown in montage. Scale
bar=10 mm. C. DiD-HCV entry is associated with actin nucleation. White arrows point to tip of nucleating actin filament. Particle trajectory is shown
to the right. Scale bar=10 mm. D. Actin nucleation event leading to active transport of DiD-HCV. Scale bar=5 mm. Numbers on the far right indicate
the % of DiD-HCV particles (of total DiD-HCV bound to cells) displaying each movement. The remaining 43.867.8% of DiD-HCV particles displayed no
movement at time of recording. E. DiD-HCV particles associated with actin stress fibers during the duration of imaging were tracked and the
velocities (mm/min) were determined. The velocities were binned from 67 DiD-HCV particles and plotted by the number of DiD-HCV particles
exhibiting a certain speed. F. Mean square displacement (MSD) plots of the trajectories from A and B showing active transport (A) and diffusion (B).
doi:10.1371/journal.ppat.1000702.g004
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a direct association between DiD-HCV and c-Cbl during entry to
eliminate the possibility of an indirect phenotype. Cells were
infected with DiD-HCV as above, fixed at various times points,
immuno-probed for c-Cbl, and visualized by confocal microscopy.
We observed specific co-localization of DiD-HCV with c-Cbl
(Figure 6D). Maximal association of DiD with c-Cbl occurred at
time points prior to HCV uncoating (Figure 6I & 2F).
HCV entry in Huh-7.5 cells is not preferentially associated
with cell-cell junctions
We next visualized the association of DiI-HCV with one of the
known entry receptors, the tetraspannin CD81. Huh-7.5 cells were
infected with CD81-GFP lentivirus and maintained for two days to
establish CD81-GFP expression. CD81-GFP had characteristic
localization to the plasma membrane. DiI-labeled HCV was
allowed to bind to the surface of Huh-7.5 cells on ice then shifted
to 37uC upon imaging. As shown in Figure 7 (Video S6), a viral
particle migrated toward the cell surface, engaged CD81-GFP on
the cell surface, and was internalized within nine minutes.
Notably, this internalization occurs outside of the area of cell-
cell contact, as indicated by the DIC image and the area of intense
CD81-GFP fluorescence (Figure 7A).
The current model of HCV entry supports trafficking of the
virus after engagement of the CD81 receptor on the cell surface to
the tight junction, where engagement of the co-receptors claudin-1
and occludin permits internalization. Our live cell imaging
approaches consistently failed to show trafficking of DiD-HCV
to sites of cell-cell contacts. Instead, virus internalization occurred
at various sites on the cell surface. We decided to look at
the localizations of endogenous receptor proteins in fixed cells.
Immunofluorescence of Huh-7.5 cells for claudin-1 and the tight
junction marker zona occludins (ZO-1) show that claudin-1 co-
localizes with ZO-1, in addition to localizing to various cell surface
locations (Figure 8A). We then investigated the apparent lack of
DiD-HCV re-localization to cell-cell contacts in fixed cells over a
time course so that we could increase our quantitation of DiD-
HCV localization. DiD-HCV infection was synchronized on ice,
unbound particles were removed, and cells were fixed at various
time points following temperature shift to determine if viral
particles accumulate at site of cell-cell contacts (Figure 8B–C). The
number of particles localized to cell-cell junctions was low (,8%)
and did not increase with time (Figure 8D). In contrast, the co-
localization of DiD-HCV with claudin-1 was much greater at 15
and 30 minutes after temperature shift (,48%) (Figure 8B and E).
Thus, the majority of DiD-HCV-claudin1 interactions occur
outside of cell-cell junctions in Huh-7.5 cells. DiD-HCV-claudin1
co-localization dropped dramatically at 60 minutes after temper-
ature shift, suggesting that the majority of particle internalization
occurred before this time point (Figure 8E). The lack of tight
junction re-localization may reflect the fact that Huh-7.5 cells are
poorly polarized, with the viral receptor claudin-1 available on the
plasma membrane outside the tight junction. Thus, in primary
polarized hepatocytes, entry may occur at the tight junction, but
our data indicates HCV entry in vitro does not require
internalization at a tight junction.
DiD-HCV particles traffic to Rab5a-positive endosomes
We next determined if the DiD-HCV particles displaying
motility on the cell surface were trafficked to an endosome.
Following clathrin pit formation, internalized cargoes converge
on the early endosome prior to being sorted for recycling or
Figure 5. HCV entry requires an intact actin cytoskeleton. A. Huh-7.5 cells were incubated with indicated concentrations of cytochalasin D for
one hour and infected with HCV pseudoparticles (HCVpp) expressing the luciferase reporter gene for four hours. Luciferase measurements were
taken at 48 hours post infection. Plotted are relative luciferase values normalized to DMSO vehicle control. Cell viability was unaffected (data not
shown). Asterisk indicates p,0.05, indicating significance. B. Huh-7.5 cells transiently expressing GFP-actin (green) were infected with DiD-HCV on ice
for 1 hour then shifted to 37uC upon imaging. Scale bar=10 mm. C. Montage of alternating time-lapse exposures of Cy5 (DiD-HCV) and GFP (actin)
from inset in (B). Height of montage=11.36 mm. Cells were treated with 2 mM cytochalasin D to depolymerize actin filaments at time indicated
(arrow). Indicated times are in minutes: seconds. D. Time-lapse montage of (C), Cy5 (DiD-HCV) only. Experiment is representative of multiple
replicates.
doi:10.1371/journal.ppat.1000702.g005
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GTPase, Rab5a. Sorting to the early endosome has been
implicated in HCV entry because a dominant negative Rab5
inhibits HCVpp entry [29].
We infected Huh-7.5 cells transiently expressing GFP-Rab5A
on ice for one hour, shifted to 37uC and began imaging for 90
minutes. In Figure 9, a DiD-HCV particle transported on the cell
surface before becoming associated with a GFP-Rab5a vesicle.
This internalization occurred outside of cell-cell junctions,
indicating that delivery of DiD-HCV to early endosomes does
not require virion entry at a tight junction.
Discussion
In this study, we combined an unbiased RNAi analysis that
identified 16 cellular proteins involved in HCV endocytosis with
the first description of single particle tracking of HCV infection.
This approach enabled us to identify new cellular cofactors of
HCV infection and to image the trafficking of HCV in relation to
these cellular proteins during internalization. In doing so, we have
confirmed the importance of clathrin-mediated endocytosis while
identifying many molecular details of the entry process. Addition-
ally, our data indicate that the current model of HCV entry, at
least into Huh-7.5 cells, requires modifications and refinement.
We propose the following model for HCV entry into Huh-7.5
cells based on our data and other studies. HCV initially relies on
actin-based transport by binding to filopodia and trafficking with
retrograde actin flow to reach the cell surface. The viral particle
diffuses randomly until the engagement of receptor molecules
CD81 and SR-B1. This complex moves laterally until encounter-
ing the entry co-factors claudin-1, -6 or -9, and possibly occludin,
typically in a region not associated with tight junctions. Once the
virus and receptor complex are associated with clathrin coated
pits, the ubiquitin E3 ligase c-Cbl, which may ubiquitylate one of
the co-receptors, is associated with subsequent virion internaliza-
tion and sorting into endosomes. The clathrin coat is linked to the
actin cytoskeleton by specialized adapter molecules epsins 1 or 3
and endocytosis is linked with clathrin coated pit curvature, fission,
and actin nucleation. Following internalization, the virion migrates
along actin stress fibers and the ubiquitylated receptor-HCV
complex is sorted by Hgs into appropriate endosomal compart-
ments. Intracellular trafficking of early endosomes away from the
plasma membrane relies on actin-based transport along stress
fibers. The virus remains in the endosome until an internal pH is
achieved that stimulates fusion occurs between the viral envelope
and the endosomal membrane, which is presumably facilitated by
the vacuolar ATPase, ATP6v0a1.
Our findings propose multiple roles for actin in HCV entry,
including early interactions with filopodial actin, actin nucleation
during internalization, and migration with actin stress fibers
following HCV internalization. Filopodial actin-based transport of
virions to the cell surface, where the entry receptors are clustered,
has been previously described for other viruses [49,50]. The
cortical actin cytoskeleton serves to provide structural plasticity to
a cell and also serves as a barrier for entry of a virus into a cell. To
get around this, many viruses trigger actin stress fiber breakdown
for efficient viral entry [57,58]; however, we found HCV to be
associated with or transport along intact stress fibers. Actin stress
fibers have been suggested to increase during HCV infection [27],
but we did not see an obvious increase in stress fibers associated
with DiD-HCV infection (data not shown).
A topic that we are actively pursuing is the precise role of c-Cbl
in HCV entry. c-Cbl is an ubiquitin E3 ligase that was been
implicated in the internalization of receptor molecules and
receptor tyrosine kinase signaling. Additionally, c-Cbl is implicated
in the receptor-mediated endocytosis of the bacterial pathogens
Rickettsia conorri and Lysteria monocytogenes [59,60]. The ubiquitin
ligase, CBLL1, is implicated in the receptor-mediated entry of
another member of the Flaviviridae, West Nile virus [61]. Our data
support a similar role in HCV infection given that c-Cbl is
required for HCV entry and that it localizes with HCV particles
Figure 6. HCV entry is associated with the clathrin endocytosis
machinery in hepatocytes. Huh-7.5 cells were infected with DiD-HCV
for 1 hour on ice then shifted to 37uC. Cells were fixed and stained for
immunofluorescence using clathrin light chain and c-Cbl antibodies. A.
Merge image of DiD-HCV (red) on cell surface with clathrin light chain
(green). B. Enlarged image inset of (A). C. 3-dimensional Z-stack
reconstruction of (A). D. Merged image of labeled DiD-HCV (red) with c-
Cbl (green). E. Enlarged image inset of (D) DiD-HCV only. F. Enlarged
image inset of (D) c-Cbl only, arrow denotes colocalized c-Cbl. Scale
bar=10 mm. G. Percent of DiD-HCV particles colocalized with clathrin
light chain (CTLC) at the indicated minutes post temperature shift. H.
Percent of DiD-HCV particles colocalized with c-Cbl at the indicated
minutes post temperature shift. n=total DiD signal. Asterisk indicates
p,0.05.
doi:10.1371/journal.ppat.1000702.g006
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interest is the identity of the ubiquitylated receptor and
investigating whether c-Cbl-dependent signal transduction path-
ways are required for HCV entry.
The data presented here suggest that HCV entry does not
require tight junctions. This is supported by another study, which
reports that disruption of tight junctions by calcium depletion
enhances HCVpp infection of polarized Caco-2 and HepG2 cells
[62,63]. Nevertheless, we think it is likely that HCV infection in
vivo is likely to occur at the tight junction, given that claudin-1 and
occludin localization is thought to be limited to the tight junction
in primary polarized hepatocytes [64]. One wonders why HCV
has evolved such a complex series of receptor interactions,
including two tight junction proteins, when tight junctions are
dispensable for entry in cell culture. We would suggest that the
driving evolutionary force for HCV to use tight junction receptor
proteins is primarily to promote cell-cell spread of the virus. HCV
infection in cell culture appears to rely on cell to cell spread, in
addition to extra-cellular infection [65]. Cell-cell spread is
independent of the virus receptor CD81, but is dependent on
claudin-1 [65,66]. Thus, HCV may tolerate a complicated,
inefficient initial entry process that is compensated by efficient
cell-cell spread of the virus. The development of robust polarized
cell culture models of HCV infection that can be used with live cell
imaging will shed light on these questions.
We believe that these data may have an impact in HCV
therapeutic development. HCV entry is an attractive target for
small molecule inhibitors since it precedes the assembly of
infectious virus and the maintenance of chronic infection is likely
to required continual rounds of re-infection of hepatocytes. The 16
host cofactors of HCV infection identified in this study include a
number of enzymes that may be successfully targeted by
pharmacological inhibitors. The development of live cell imaging
of HCV infection greatly expands our ability to study dynamic
HCV-cellular interactions. Additionally, it will be an important
approach to characterizing the mechanism of action of HCV entry
inhibition by small molecules and neutralizing antibodies.
Materials and Methods
Cells and virus
Huh-7.5 cells [67] were grown in Dulbecco’s modified high
glucose media (DMEM; Invitrogen) supplemented with 10% fetal
bovine serum (FBS; Invitrogen), nonessential amino acids (NEAA,
0.1 mM; Gibco), 1% penicillin-streptomycin (Gibco), and main-
tained in 5% CO2 at 37uC. For transfection of viral RNA, Huh-
7.5 cells were electroporated with HCV genotype 2a infectious
clone pJFHxJ6-CNS2C3 RNA as described in [33,68]. Viral
supernatants were collected daily from up to 5 passages of the
electroporated cells, filtered through a 0.22 micron cellulose
nitrate filter, and kept at 4uC protected from light. Viral titers were
determined by limiting dilution and immunohistochemical
staining using an antibody directed to NS5A (9E10) as described
[7,69].
Highly infectious stock preparation
Viral supernatants were concentrated by polyethylene glycol
8000 (PEG) precipitation [7]. Briefly, filtered viral supernatants
were incubated overnight with PEG (final, 8% (w/v)) followed by
centrifugation (80006g, 20 min) and resuspended in 10 mL of
spent supernatant. Virus was centrifuged (80006g, 15 min) and
resuspended in a final volume of 1 mL of cell culture DMEM.
Virus was labeled by adding 5 mL( 5mM final concentration) of
lipophilic dye, DiD (Invitrogen, excitation 644 nm/emission
665 nm) or DiI (Invitrogen, excitation 549 nm/emission
565 nm) to the 1 mL of concentrated virus. Virus and dye were
incubated for 1 hour with shaking at room temperature while
protected from light. Labeled virus was loaded onto a 20–80%
Figure 7. HCV enters cells in association with CD81. Huh-7.5 cells expressing CD81-GFP were infected with DiI fluorescently labeled HCV (red)
on ice. Cells were shifted to 37uC on the microscope stage. A. Left: DIC image. Right: Merge image of GFP and DiI fluorescence. The box highlights the
live cell montage shown in panel (B). B. Montage of alternating time-lapse exposures of Cy3 (DiI-HCV) and GFP (CD81-GFP). Alternating 100ms
exposures of Cy3 and GFP were taken every 10 seconds for several minutes post temperature shift. Time is in minutes: seconds. Scale bar=10 mm.
doi:10.1371/journal.ppat.1000702.g007
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and centrifuged for 16 hours at 4uC and 34K rpm. 1 mL fractions
were isolated after puncture of the bottom of the tube. Each
fraction was titered to determine an infectious dose 50 (ID50)/mL
by immunohistochemical staining as described above. Viral RNA
was isolated by Trizol-LS (Invitrogen) extraction from 100 mLo f
each fraction. The copies of viral RNA present in each fraction
were determined by quantitative real time reverse transcriptase
(RT) PCR analysis as described previously [33]. RT-PCR was
performed using an Applied Biosystems 7300 Real Time PCR
machine under the following conditions: 30 min at 70uC, 6 min at
95uC, then cycled 50 times at 95uC for 15 sec, 55uC for 30 sec,
72uC for 15 sec. The absolute RNA copy number was determined
for each isolated fraction by comparison to viral RNA concentra-
tion standards. The specific infectivity per RNA copy of each
fraction was determined by dividing the RNA quantity by the
ID50/mL. DiD-HCV was isolated from the sucrose for subse-
quent imaging studies by ultracentrifugation at 36K rpm for
2 hours, and then resuspended in 1 mL of DMEM supplemented
with 10% FBS, 0.1 mM NEAA, and 1% penicillin-streptomycin.
Gradient fractions that contain DiD-HCV with specific infectiv-
ities of ,10, such as fraction 5 in Figure 1, were used for imaging
studies.
Immunodepletion of DiD-HCV
100 mL fractions of DiD-HCV were incubated with 10 mgo fE 2
(CBH5) or isotype control (RO4) antibodies (generous gifts from
Steven Foung) already bound to IgG beads (Sigma) for 1 hour
with shaking at 4uC. Beads were spun down by centrifugation at
120006g for 5 minutes at 4uC. Unbound particles in the
supernatant were removed using a 28G needle. 10 mLo f
supernatant or input DiD-HCV fraction were spotted onto poly-
lysine coverslips and immuno-stained as described below.
Drug inhibitor studies
Cytochalasin D (Sigma) was kept at a stock concentration of
0.5 mg/mL in DMSO at -20uC and diluted in 5% DMEM for
inhibitor studies. Cells were seeded in a 96 well plate and treated
for approximately 1 hour with indicated concentrations of
cytochalasin D, then infected with pseudotyped HCV viral
particles in drugged media. Viral inoculum was replaced with
fresh 5% DMEM approximately 4 hours later and then cells were
incubated for 48 hours. After 48 hours, the cell lysates were
harvested and tested via luciferase assay (Promega).
For the DiD-core uncoating assay in the presence of NH4Cl,
Huh-7.5 cells grown on 13 mm round coverslips were incubated
with 100 mM NH4Cl for 2 hours at 37uC. Cells were incubated
on ice for 10 minutes before the addition of DiD-HCV (MOI=1)
for 1 hour on ice. NH4Cl was present throughout the duration of
the experiment.
Cell viability assay
Viability was assessed using the CellTiter-Glo luminometer
viability assay as directed by the manufacturer (Promega).
Plasmid constructs
CD81 was PCR amplified from Huh7.5 cDNA with primers
(59-GGATCCATGGAGTGGAGGGCTG-39,5 9-GGATCCG-
TACACGGAGCTGTT CC-39) to allow insertion of BamHI
restriction sites (underlined sequence) flanking the gene. Rab5A
was cloned as N-terminal GFP fusion in pmGFP-C1 with a 59
HindIII site engineered into the forward primer and a 39 KpnI site
engineered into the reverse primer: (F: 59-G C AAGCTTCAAC-
CATGGCTAGTCGAGGCGCAA-39,R :5 9-A C GGTACCT-
TAGTTACTACAACACTGATTCCT-39). All plasmids were
confirmed by sequence analysis using an Applied Biosciences
3730XL sequencer. The CD81 PCR product was initially cloned
into a pCR 2.1-TOPO plasmid (Invitrogen) via the manufacturer’s
instructions and then subcloned into pTRIP-GFP (an HIV-based
transfer vector) [70,71] to result in the CD81-GFP plasmid. The
Rab5a PCR product was cloned directly into pmGFP-C1,
resulting in the plasmid GFP-Rab5a. The sequence, gene
orientation and frame were confirmed via sequencing. The
GFP-actin construct was a generous gift from Jerold Turner
(University of Chicago).
Figure 8. HCV-Claudin-1 association outside of cell-cell junc-
tions. Huh-7.5 cells were stained by immunofluorescence for the tight
junction proteins, zona occludens-1 (ZO-1), and claudin-1 (CLDN-1) in
the presence or absence of DiD-HCV infection. A. CLDN-1 staining is not
restricted to areas of ZO-1 localization. Huh-7.5 cells grown to
confluency were fixed in 4% paraformaldehyde and stained for CLDN-
1 and ZO-1. B. Huh-7.5 cells were infected with density gradient purified
DiD-HCV for 1 hour on ice. Cells were shifted to 37uC, fixed in 4%
paraformaldehyde at various time points post temperature shift, and
stained for CLDN-1 by immunofluorescence. Shown are cells fixed at 15,
30, and 60 minutes post temperature shift. Nuclei are stained with DAPI
(blue). C. Localization of DID-HCV (red) with the tight junction marker,
ZO-1 (green). Shown are cells fixed at 15, 30, and 60 minutes post
temperature shift. D. Quantification of percent co-localized DiD-HCV
positive for ZO-1 fluorescence at the indicated minutes post
temperature shift. E. Quantification of percent colocalized DiD-HCV
positive for CLDN-1 fluorescence at the indicated minutes post
temperature shift. n=total DiD signal. Scale bar=10 mm.
doi:10.1371/journal.ppat.1000702.g008
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To produce CD81-GFP lentiviral stocks, 293T cells were
transfected with the following plasmids: a plasmid containing the
HIV gag and pol genes, and a plasmid containing the vesicular
stomatitis virus glycoprotein (VSV-G), and CD81-GFP plasmids.
Plasmids were transfected into 293T cells using Lipofectamine
2000 per the manufacturer’s instructions. Supernatants containing
the pseudotyped virus was harvested after 48 hours at 37uC,
passed through a 0.45mM filter, aliquoted, and stored at 280uC.
RNA interference assay
The primary screen includedsiRNAs that weredesigned totarget
140 genes (4 siRNAs per gene) (Dharmacon, Inc.). Genes important
for infectiousHCVproductionweresubsequently silencedwithfour
individual siRNAs targeting the gene to eliminate the possibility of
the phenotype being associated with off target effects. RNAi assays
were performed as previously described [35,72]. Briefly, 1610
6
Huh-7.5 cells in 0.05 ml of PBS pH 7.4 were electroporated with
125 picomoles of siRNA for 5 pulses of 770 volts for 99
microseconds with one- second intervals on a BTX 830 electro-
porator with 96-well attachment. Cells were plated and infected at
72 hours after electroporation with a multiplicity of 0.5 infectious
HCV particles per cell for 6 hours, rinsed with media, then
maintained for 2 days at 37uC. After infection, the supernatants
were collected and analyzed for extra-cellular infectious virus via
limiting titer dilution as described previously [69].
For the uncoating assay in siRNA expressing cells, 1610
6 cells
were transfected with 125 pmol of either siIRR and siCD81
constructs using Lipofectamine RNAi max reagent (Invitrogen).
siRNAs were allowed to express for 48 hours before the cells were
seeded onto 13 mm round coverslips. Cells were infected for the
uncoating assay and fixed and stained using a core antibody as
described below. The silenced cells were also tested in the HCV
pseudoparticle entry assay described below.
HCV pseudoparticle entry assay
HCVpp were generated as described previously [33]. Huh-7.5
cells were infected 72 h after siRNA electroporation with HCVpp
and 8 mg/ml polybrene (Sigma) for 4 h. Cell lysates were collected
at 48 h after HCVpp infection, and firefly luciferase (Promega)
activity was measured using a 96-well luminometer (Centro LB
960, Berthold Technologies).
Live cell imaging
Huh-7.5 cells were transfected with GFP-Rab5a or GFP-actin
constructs using Lipofectamine 2000 (Invitrogen) as per manufac-
Figure 9. HCV is transported in Rab5a-containing early endosomes. A. Live cell imaging of Huh-7.5 cells transfected with GFP-Rab5a prior to
imaging and infected with DiD-HCV for 1 hour on ice then shifted to 37uC upon imaging. Alternating Cy5 (DiD-HCV) and GFP (GFP-Rab5a) 100 ms
exposures were taken every 2 seconds for several minutes. Edge of cell outlined. Trajectory traveled in white. B. Inset of A shown as montage of
alternating Cy5 and GFP exposures. Scale bar=5 mm.
doi:10.1371/journal.ppat.1000702.g009
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were seeded onto poly-lysine coated 35 mm fluorodishes (World
Precision Instruments) at a confluency of 60–70% and allowed to
adhere for 24 hours prior to imaging. Alternatively, Huh-7.5 cells
were infected with CD81-GFP lentivirus in the presence of 1 mg/
mL polybrene and allowed to establish expression for 48 hours
followed by seeding onto fluorodishes as above. Cells were washed
with PBS and 100 mL of virus diluted in 400 mL of DMEM was
added to each dish on ice and protected from light. Experiments
were performed at MOIs of 0.2 to 1.0, dependent on the
calculated specific infectivity of the purified DiD-HCV stock,
which yielded on average 4 DiD-HCV particles per cell. After
1 hour, the media was replaced with fresh cold 10% FBS DMEM
containing 25 mM HEPES buffered saline (Gibco). The dish was
placed on a heated stage at 37uC on an Olympus DSU Spinning
Disc confocal microscope.
Cells were visualized using a 10061.45 N.A oil-immersion
objective. DiD-HCV or DiI-HCV particles were visualized using a
Cy5 or Cy3 filter set, respectively. GFP-Rab5a, GFP-actin, or
CD81-GFP proteins were visualized using an EGFP filter set
coupled to a Hamamatsu back-thinned EM-CCD high speed/
sensitivity camera. Images were acquired by taking sequential
Cy5/EGFP exposures at 100 ms every 5 seconds for 50-100
frames up to 2 hours post temperature shift with the camera
intensification set at 255 using the Slidebook software. Images
were processed using the Image J software (National Institutes of
Health). Trajectories and corresponding velocities were deter-
mined using the Image J plug-in, SpotTracker [73]. Mean square
displacement was determined using the following equation:
MSD(t)=Æ(x(t)-(x(t+t))
2+(y(t)-(y(t+t))
2æ
Where x and y are the coordinates of the particle, t is the lag
time, and the brackets represent the time average [74].
Immunofluorescence microscopy
Huh-7.5 cells were seeded onto 13 mm round coverslips at a
confluency of 60–70%. Cells were washed once with ice cold PBS
and infected with highly infectious DiD-HCV at a MOI of 0.5 on
ice for 1 hour and protected from light. Unbound virus was
washed off with cold PBS, DMEM+5%FBS media was added, and
cells were transferred to the 37uC incubator. Coverslips were fixed
in paraformaldehyde at 0 min, 15 min, 30 min, 1 hour, 1.5 hour,
and 2 hours post temperature shift and kept at 4uC until
processed. Coverslips were permeabilized with 0.1% Triton X-
100 and blocked in 0.1% Triton X-100-50% goat serum in PBS.
Coverslips were incubated overnight with primary antibodies as
follows: 1:100 anti-core (Virostat), 1:200 anti-c-Cbl (Cell Signaling
Antibodies), 1:200 anti-clathrin light chain (Santa Cruz), 1:500
anti ZO-1 (Zymed), and 1:100 anti-claudin-1 (Zymed) in blocking
buffer. Following primary antibody incubation, coverslips were
washed two times with PBS and incubated with Alexa Fluor 488
conjugated secondary antibody (1:1000) for 1 hour before
mounting on either Mowiol (Sigma) or Prolong Gold (Invitrogen)
reagent. Actin was stained using Alexa Fluor 488 phalloidin
(Invitrogen) at 1:40 in PBS following paraformaldehyde fixation.
For immuno-staining of DiD-HCV particles for viral proteins,
particles were aliquoted onto poly-lysine treated coverslips and
fixed in 4% paraformaldehyde and permeabilized in 50% goat
serum plus 0.1% TX-100. DiD-HCV particles were incubated
with 1:100 anti-core (Virostat) or 1:100 anti-E2 (CBH5) for
1 hour. Following primary antibody incubation, coverslips were
washed and incubated with fluorescent conjugated secondary
antibody as above.
Coverslips were imaged for DID labeled virus by using the Cy5
filter set and Alexafluor 488 was visualized using the GFP filter set.
Immunofluorescence images were taken using an Olympus DSU
Spinning Disc Confocal microscope with a 100X NA 1.45
objective where the camera intensification was set to 255. DiD-
HCV images were acquired at an exposure time of 1 second using
the Cy5 filter set and DAPI stained nuclei were visualized at an
exposure time of 20 ms using the 350 filter set. Alexa fluor 488
conjugated secondary antibodies were detected using the EGFP
filter set and the following exposure times: clathrin light chain 1
second, C-Cbl, 1 second, CLDN-1 and ZO-1, 500 ms. Post-
acquisition, images were processed using Image J (NIH).
Specifically, each red, green, and blue stack was separated into
individual channels. Each channel was processed by using the
subtract background tool followed by the smooth option. Channels
were merged into a single image and the contrast was adjusted.
For colocalization analysis two Image J plugins were used. The
first, RGB profiler (Christophe Laummonerie), provided intensity
profiles of each channel corresponding to a line drawn on an
image. Colocalization was confirmed when peaks above back-
ground overlapped. The Image J plugin, colocalization, was also
used to confirm overlapping pixels in the separate channels.
Supporting Information
Figure S1 Cell viability following treatment with indicated
siRNAs. Cell viability was determined five days after electropo-
ration of siRNAs and quantified by a luminescence-based cell
viability assay (Promega) that measures intracellular ATP levels.
Values are measured relative to IRR siRNA-treated cells and
standard error of the mean is shown.
Found at: doi:10.1371/journal.ppat.1000702.s001 (0.03 MB PDF)
Table S1 Genes and siRNAs tested in the RNA interference
screen.
Found at: doi:10.1371/journal.ppat.1000702.s002 (0.10 MB PDF)
Table S2 Quantitative real time RT-PCR assays.
Found at: doi:10.1371/journal.ppat.1000702.s003 (0.05 MB PDF)
Video S1 Transport of DiD-HCV (red) along filopodia labeled
with GFP-actin (green). Montage of video is shown in Figure 4A.
Playback time is 106real speed. Scale bar=10mm.
Found at: doi:10.1371/journal.ppat.1000702.s004 (6.31 MB
MOV)
Video S2 Diffuse movement of DiD-HCV on the cell surface.
Video of the montage shown in Figure 4B. Playback time is 106
real speed. Scale bar=10mm.
Found at: doi:10.1371/journal.ppat.1000702.s005 (4.37 MB
MOV)
Video S3 Actin nucleation adjacent to a DiD-HCV particle.
DiD-HCV leaves the focal plane, indicating an endocytic event.
Video of the montage shown in Figure 4C. Playback time is 106
real speed. Scale bar=10mm.
Found at: doi:10.1371/journal.ppat.1000702.s006 (0.70 MB
MOV)
Video S4 DiD-HCV particle is transported by the nucleation of
an asscociated actin cluster. Video of the monatge shown in
Figure 4D. Playback time is 106real speed. Dimensions of video
are 8.48610.08 mm.
Found at: doi:10.1371/journal.ppat.1000702.s007 (0.06 MB
MOV)
Video S5 Actin depolymerization disrupts directional movement
of DiD-HCV particles. Video of the montage shown in Figure 5C.
Shown is a representative image of GFP-actin expressing cells
treated with 2mM Cytochalasin D during live cell imaging
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seconds. Image plane was readjusted after addition of Cytocha-
lasin D to the imaging chamber and imaging took place for
another 365 seconds. Playback time is 106 real speed. Scale
bar=10mm.
Found at: doi:10.1371/journal.ppat.1000702.s008 (0.17 MB
MOV)
Video S6 Dil-HCV associates with CD81-GFP during entry into
cells. Video of the montage shown in Figure 7B. DiI-HCV is
associated with CD81-GFP on the cell surface, then enters into the
cell. Internalization occurs away from the cell-cell junction.
Playback time is 106real speed. Scale bar=10mm.
Found at: doi:10.1371/journal.ppat.1000702.s009 (4.72 MB
MOV)
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